CRISPR Therapeutics AG (NASDAQ:CRSP)

45.42
Delayed Data
As of Sep 29
 -0.35 / -0.77%
Today’s Change
38.94
Today|||52-Week Range
72.00
+11.73%
Year-to-Date

Stock Price Forecast

The 25 analysts offering 12-month price forecasts for CRISPR Therapeutics AG have a median target of 75.00, with a high estimate of 220.00 and a low estimate of 43.00. The median estimate represents a +65.13% increase from the last price of 45.42.

Analyst Recommendations

The current consensus among 29 polled investment analysts is to Buy stock in CRISPR Therapeutics AG. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$2.06
Sales
$12.9M
Reporting Date
Nov 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -110.31%
 
 
 
 
 
 
Growthannually 28.15%
 
 
 
 
 
 

Sales

Growthquarterly -81.60%
 
 
 
 
 
 
Growthannually 16,965.70%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.